Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Palliative Care for Inclusion Body Myositis, a Case Report

Kamini E. Kuchinad, MD, MPH, Ambereen Mehta, MD, MPH, David Wu, MD, & Jemima Albayda, MD  |  Issue: September 2024  |  September 7, 2024

Reflecting back, Mrs. F thinks earlier goals-of-care conversations would have been helpful. And as Mr. F continued to decline, there was no central person to guide them through the process.

Discussion

IBM is a serious and devastating illness without any known, effective cure. Excellent person-centered care of patients with IBM and their care partners must include palliative care—identification and management of total suffering, which includes physical, psychosocial, spiritual/existential and financial distress. Increasing access to palliative care requires educating rheumatologists about how to incorporate palliative care modalities into their management framework and identifying when referral to specialty palliative care is appropriate (see Table 2).

Click to enlarge.

Complex symptom management is part of holistic IBM care.

Like Mr. F, many individuals with IBM have limited contact with the healthcare system after diagnosis because of the perception that available medical care is futile given the incurable nature of the disease; however, addressing symptom burden may not only relieve suffering, but may also improve the patient’s ability to continue receiving IBM-directed therapies.

For example, regular evaluation for swallowing dysfunction can allow for earlier interventions with such procedures as esophageal dilations or speech therapy, and prompt early conversations regarding PEG placement.6,7 Management of dysphagia, such as dietary modification, oral care and education, can be beneficial in managing symptoms for individuals with IBM and progressive swallowing dysfunction.8

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Diaphragm weakness and respiratory failure can also be seen. When Mr. F’s respiratory status was declining, a pulmonologist put him on a bi-level positive airway pressure machine (BiPAP) machine at night, as well as a cough assist machine, interventions his wife felt improved his quality of life and prolonged his life. Routine incorporation of physical therapy and occupational therapy is the mainstay of treatment to maintain strength and prevent muscle atrophy for individuals with IBM. Early referral and regular monitoring can allow adoption of adaptive strategies/assistive devices to maintain physical function and prevent falls secondary to IBM.6,9

Further, Mr. F struggled with untreated depression and anxiety surrounding his illness, which were left unmanaged throughout the course of his illness and negatively impacted his quality of life.

High-quality communication facilitates exploration of goals & complex decision making.

Poor communication and the lack of timely goals-of-care discussions exacerbated the turmoil and isolation that Mr. and Mrs. F experienced. Discussions surrounding PEG tube placement were limited and did not incorporate Mr. F’s preferences surrounding his care. Informed, shared decision making is necessary when considering this procedure because it has not been found to prevent aspiration.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsMyositis Tagged with:case reportEditor's Pickinclusion body myositis (IBM)palliative care

Related Articles

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Myositis Mysteries

    January 1, 2008

    Why isn’t my myositis patient getting better?

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

    Tashatuvango / shutterstock.com

    Myositis-Specific Antibodies Identified

    January 16, 2020

    The idiopathic inflammatory myopathies (IIM) encompass eight categories: 1) dermatomyositis (DM) in adults, 2) juvenile dermatomyositis, 3) amyopathic DM, 4) cancer-associated DM, 5) polymyositis, 6) immune-mediated necrotizing myopathy, 7) inclusion body myositis, and 8) overlap myositis.1 These categories help classify the myopathies based on clinical and histologic features. The incidence of IIM is estimated at…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences